研究について【2021年】

英文原著論文　Original papers

発刊済のものはabstractまたは本文にリンクしてあります。
Published papers are linked to PubMed


Kataoka Y, Anan K, Taito S, Tsujimoto Y, Kurata Y, Wada Y, Maruta M, Kanaoka K, Oide S, Takahashi S, Nango E.

Quality of clinical practice guidelines in Japan remains low: A cross-sectional meta-epidemiological study.

J Clin Epidemiol. 2021 Oct;138:22-31.



Hosokawa Y, Okada M, Suemori K, Hamaguchi N, Miyoshi KI, Takagi T, Teraoka M, Yamada H, Ishizaki J, Matsumoto T, Hato N.

The association between ear involvement and clinical features and prognosis in ANCA-associated vasculitis.

Auris Nasus Larynx. 2021 Oct;48(5):885-889.



Yasuda S, Najima Y, Konishi T, Yamada Y, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Shingai N, Yoshioka K, Inamoto K, Mukae J, Toya T, Igarashi A, Shimizu H, Kobayashi T, Kakihana K, Sakamaki H, Kawamata N, Ohashi K, Doki N.

Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study

Leuk Res. 2021 Sep;108:106627.



Tamai Y, Ohto H, Yasuda H, Takeshita A, Fujii N, Ogo H, Yazawa Y, Hato T, Mitani K, Suzuki K, Yokohama A, Kato Y, Abe M, Kumagawa M, Ueda Y, Nollet KE, Cooling L, Kitazawa J; Pediatric RBC Alloimmunization Consortium.

Allo-anti-M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion.

Transfusion. 2021 Sep;61(9):2718-2726.



Konishi T, Sekiya N, Otsuka Y, Konuma R, Wada A, Adachi H, Kishida Y, Nagata A, Yamada Y, Noguchi Y, Marumo A, Mukae J, Inamoto K, Toya T, Igarashi A, Najima Y, Kobayashi T, Sakamaki H, Ohashi K, Doki N.

Changes in vaccination strategies contribute to the development of invasive pneumococcal disease in allogeneic hematopoietic stem cell transplantation recipients: a retrospective study for promoting vaccination

Int J Hematol. 2021 Aug;114(2):263-270.



Konishi T, Kusakabe S, Hino A, Inamoto K, Yoshifuji K, Kiridoshi Y, Takeshita K, Sasajima S, Toya T, Igarashi A, Najima Y, Kobayashi T, Doki N, Motooka D, Nakamura S, Suyama M, Suda W, Shiota A, Atarashi K, Hattori M, Honda K, Yokota T, Ohashi K, Shibayama H, Fukushima K, Kakihana K.

Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease

Bone Marrow Transplant. 2021 Jul;56(7):1728-1731.



Yokoe Y, Tsuboi N, Imaizumi T, Kitagawa A, Karasawa M, Ozeki T, Endo N, Sawa Y, Kato S, Katsuno T, Maruyama S, Yamagata K, Usui J, Nagata M, Sada KE, Sugiyama H, Amano K, Arimura Y, Atsumi T, Yuzawa Y, Dobashi H, Takasaki Y, Harigai M, Hasegawa H, Makino H, Matsuo S; Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis and for Intractable Renal Disease.

Clinical impact of urinary CD11b and CD163 on the renal outcomes of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Nephrol Dial Transplant. 2021 Jul 23;36(8):1452-1463.



Iwata S, Okada M, Suemori K, Teraoka M, Yamada H, Ishizaki J, Matsumoto T, Hato N.

The hearing prognosis of otitis media with ANCA-associated vasculitis.

Auris Nasus Larynx. 2021 Jun;48(3):377-382.



Mori Y, Jinnouchi F, Takenaka K, Aoki T, Kuriyama T, Kadowaki M, Odawara J, Ueno T, Kohno K, Harada T, Yoshimoto G, Takase K, Henzan H, Kato K, Ito Y, Kamimura T, Ohno Y, Ogawa R, Eto T, Nagafuji K, Akashi K, Miyamoto T.

Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data.

Bone Marrow Transplant. 2021 Apr;56(4):853-862.



Ishizaki J, Takemori A, Horie K, Hiraoka D, Suemori K, Matsumoto T, Sada KE, Amano K, Harigai M, Arimura Y, Makino H, Takenaka K, Takemori N, Hasegawa H; Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan.

Usefulness of tissue inhibitor of metalloproteinase 1 as a predictor of sustained remission in patients with antineutrophil cytoplasmic antibody-associated vasculitis

Arthritis Res Ther. 2021 Mar 20;23(1):91.



Ochi T, Maruta M, Tanimoto K, Kondo F, Yamamoto T, Kurata M, Fujiwara H, Masumoto J, Takenaka K, Yasukawa M.

A single-chain antibody generation system yielding CAR-T cells with superior antitumor function.

Commun Biol. 2021 Mar 2;4(1):273.



Takemori A, Ishizaki J, Nakashima K, Shibata T, Kato H, Kodera Y, Suzuki T, Hasegawa H, Takemori N.

BAC-DROP: Rapid Digestion of Proteome Fractionated via Dissolvable Polyacrylamide Gel Electrophoresis and Its Application to Bottom-Up Proteomics Workflow.

J Proteome Res. 2021 Mar 5;20(3):1535-1543.



Kikuchi R, Tsuboi N, Sada KE, Nakatochi M, Yokoe Y, Suzuki A, Maruyama S, Murohara T, Matsushita T; Research Committee of Intractable Vasculitis Syndrome and Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan, Amano K, Atsumi T, Takasaki Y, Ito S, Hasegawa H, Dobashi H, Ito T, Makino H, Matsuo S.

Vascular endothelial growth factor (VEGF)-A and VEGF-A 165 b are associated with time to remission of granulomatosis with polyangiitis in a nationwide Japanese prospective cohort study.

Ann Clin Biochem. 2021 Mar;58(2):86-94.



Suemori K, Saijo M, Yamanaka A, Himeji D, Kawamura M, Haku T, Hidaka M, Kamikokuryo C, Kakihana Y, Azuma T, Takenaka K, Takahashi T, Furumoto A, Ishimaru T, Ishida M, Kaneko M, Kadowaki N, Ikeda K, Sakabe S, Taniguchi T, Ohge H, Kurosu T, Yoshikawa T, Shimojima M, Yasukawa M.

A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome.

PLoS Negl Trop Dis. 2021 Feb 22;15(2):e0009103.



Ohmachi K, Kinoshita T, Tobinai K, Ogawa G, Mizutani T, Yamauchi N, Fukuhara N, Uchida T, Yamamoto K, Miyazaki K, Tsukamoto N, Iida S, Utsumi T, Yoshida I, Imaizumi Y, Tokunaga T, Yoshida S, Masaki Y, Murayama T, Yakushijin Y, Suehiro Y, Nosaka K, Dobashi N, Kuroda J, Takamatsu Y, Maruyama D, Ando K, Ishizawa K, Ogura M, Yoshino T, Hotta T, Tsukasaki K, Nagai H; Japan Clinical Oncology Group.

A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial.

Blood Adv. 2021 Feb 23;5(4):984-993.



Takenaka K, Onishi Y, Mori T, Hirakawa T, Tada Y, Uchida N, Kobayashi T, Kanda Y, Ozawa Y, Ota S, Iida H, Fukushima K, Kimua T, Fukuda T, Atsuta Y, Matsuto K, Yamazaki H, Nakasone H.

Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation.

Transplant Cell Ther. 2021 Jan;27(1):82.e1-82.e8.



Nakamura Y, Takenaka K, Yamazaki H, Onishi Y, Ozawa Y, Ikegame K, Matsuoka KI, Toubai T, Ueda Y, Kanda Y, Ichinohe T, Atsuta Y, Mori T.

Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria.

Int J Hematol. 2021 Jan;113(1):122-127.



Onishi Y, Mori T, Yamazaki H, Takenaka K, Yamaguchi H, Shingai N, Ozawa Y, Iida H, Ota S, Uchida N, Miyamoto T, Katayama Y, Kato J, Yoshioka S, Onizuka M, Ichinohe T, Atsuta Y; Adult Aplastic Anemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia.

Ann Hematol. 2021 Jan;100(1):217-228.



Iriguchi S, Yasui Y, Kawai Y, Arima S, Kunitomo M, Sato T, Ueda T, Minagawa A, Mishima Y, Yanagawa N, Baba Y, Miyake Y, Nakayama K, Takiguchi M, Shinohara T, Nakatsura T, Yasukawa M, Kassai Y, Hayashi A, Kaneko S.

A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.

Nat Commun. 2021 Jan 18;12(1):430.



Yamanaka S, Miyagawa M, Sugawara Y, Hasebe S, Fujii T, Takeuchi K, Tanaka K, Yakushijin Y.

The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphoma.

Int J Clin Oncol. 2021 Jan;26(1):225-232.